Valuation : EirGenix Inc.

Market Cap 14.35B 454M 390M 367M 335M 628M 42.82B 629M 4.34B 1.68B 21.97B 1.7B 1.67B 70.78B P/E 2026 *
-31.6x
P/E 2027 * 84.3x
Enterprise Value 13.1B 414M 356M 335M 306M 573M 39.1B 575M 3.96B 1.54B 20.06B 1.56B 1.52B 64.63B EV / Sales 2026 *
8.89x
EV / Sales 2027 * 5.77x
Free-Float
59.94%
Yield 2026 *
-
Yield 2027 * -
1 day+0.31%
1 week-3.61%
Current month-0.21%
1 month+0.10%
3 months+8.34%
6 months-19.65%
Current year-22.12%
1 week 47.3
Extreme 47.3
49
1 month 47.3
Extreme 47.3
53
Current year 40.15
Extreme 40.15
67.6
1 year 40.15
Extreme 40.15
84.3
3 years 40.15
Extreme 40.15
111
5 years 40.15
Extreme 40.15
163.5
10 years 21.55
Extreme 21.55
195
Manager TitleAgeSince
Chief Executive Officer - 01/04/2013
Director of Finance/CFO - 03/05/2016
Corporate Officer/Principal - 20/05/2019
Director TitleAgeSince
Director/Board Member - 14/06/2013
Director/Board Member - 13/09/2016
Chairman - 10/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
+0.31%-3.61%-24.33%-48.77% 454M
-1.87%+4.22%+44.36%+1.14% 82.65B
-0.76%+0.94%-18.84%-35.43% 60.24B
-2.23%+5.48%+478.96%+34.47% 58.11B
-2.03%-2.62%-8.63%+29.27% 49.68B
+0.76%-1.44%+0.86%+156.16% 46.66B
-1.64%+1.07%+56.98%-16.26% 32.63B
-0.98%+1.91%+46.30%+100.59% 25.69B
-1.07%-2.41%+0.80%+186.56% 22.73B
-0.35%+0.89%+64.42%+106.46% 16.54B
Average -0.99%-0.09%+64.09%+51.42% 39.54B
Weighted average by Cap. -1.27%+0.81%+86.23%+42.33%

Financials

2026 *2027 *
Net sales 1.47B 46.59M 40.09M 37.72M 34.46M 64.46M 4.4B 64.63M 446M 173M 2.26B 175M 171M 7.27B 2.34B 74.06M 63.73M 59.96M 54.77M 102M 6.99B 103M 708M 275M 3.59B 278M 272M 11.56B
Net income -458M -14.48M -12.46M -11.72M -10.71M -20.03M -1.37B -20.08M -138M -53.74M -701M -54.36M -53.17M -2.26B 172M 5.44M 4.68M 4.4M 4.02M 7.52M 513M 7.54M 52.01M 20.18M 263M 20.41M 19.97M 848M
Net Debt -1.25B -39.41M -33.92M -31.91M -29.15M -54.53M -3.72B -54.68M -377M -146M -1.91B -148M -145M -6.15B -838M -26.49M -22.79M -21.44M -19.59M -36.65M -2.5B -36.75M -253M -98.33M -1.28B -99.46M -97.29M -4.13B
Logo EirGenix Inc.
EirGenix Inc is a Taiwan-based company primarily engaged in the development of antibody drugs and the manufacture of biopharmaceuticals. Its main businesses include the provision of Contract Development & Manufacturing Organization (CDMO) services, the construction of cell strain, the manufacture of clinical trial medicine, analytical science and protein identification, and PIC/S manufacturing plant to provide clinical trial drug production.
Employees
1,000
Date Price Change Volume
04/09/26 TWD 48.05 +0.31% 364,628
03/09/26 TWD 47.90 -1.24% 308,436
02/09/26 TWD 48.50 +1.04% 236,897
01/09/26 TWD 48.00 -0.31% 676,497
31/08/26 TWD 48.15 -3.41% 813,553
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
48.05TWD
Average target price
111.00TWD
Spread / Average Target
+131.01%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6589 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!